Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Design, synthesis, and molecular modeling of new 3(2H)-pyridazinone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors — Zeynep Özdemir (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Design, synthesis, and molecular modeling of new 3(2H)-pyridazinone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors
ZÖ
Shared by
Zeynep Özdemir
İnönü University
Design, synthesis, and molecular modeling of new 3(2H)-pyridazinone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors
Article
2017
en
Authors
+3 more
ZÖ
Zeynep Özdemir
İnönü University
HY
Hayriye Yılmaz
SS
Suat Sarı
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2020
QSAR and pharmacophore analysis on pyridazinone derivatives as acetylcholinesterase inhibitors
Mehmet Abdullah Alagöz
,
Zeynep Özdemir
,
Yaren Nur Zenni
,
Tuba Yilmaz
,
Tíjen Önkol
Article
2019
A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies
Azime Berna Özçelik
,
Zeynep Özdemir
,
Suat Sarı
,
Semra Utku
,
Mehtap Uysal
Article
2022
Synthesis, Molecular Docking and Molecular Dynamics Simulation Studies of Some Pyridazinone Derivatives as Lipase Inhibitors
Mehmet Abdullah Alagöz
,
İnci Selin Doğan
,
Sıla Özlem Şener
,
Zeynep Özdemir
Article
2021
Synthesis, Cytotoxicity and Anti-Proliferative Activity against AGS Cells of New 3(2H)-Pyridazinone Derivatives Endowed with a Piperazinyl Linker
Mehmet Abdullah Alagöz
,
Zeynep Özdemir
,
Mehtap Uysal
,
Simone Carradori
,
Marialucia Gallorini
,
Alessia Ricci
,
Susi Zara
,
Bijo Mathew
Article
2020
Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors
Zeynep Özdemir
,
Mehmet Abdullah Alagöz
,
Harun Uslu
,
Arzu Karakurt
,
Açelya Erikçi
,
Gülberk Uçar
,
Mehtap Uysal
Discussion(0)
No comments yet. Be the first to comment.